Prostatis Group’s iShares Select U.S. REIT ETF ICF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Sell
7,795
-88
-1% -$5.91K 0.12% 110
2026
Q1
$488K Sell
7,883
-331
-4% -$20.7K 0.12% 105
2025
Q4
$490K Buy
8,214
+660
+9% +$40.1K 0.12% 104
2025
Q3
$465K Buy
7,554
+262
+4% +$16K 0.12% 100
2025
Q2
$446K Buy
+7,292
New +$442K 0.13% 101

Other funds holding ICF

Prostatis Group's ICF Position: Q2 2026 in Review

Prostatis Group reduced its iShares Select U.S. REIT ETF (ICF) stake by 1.1% in Q2 2026, selling an estimated $5.91K and leaving 7,795 shares worth $527K. The position accounts for 0.12% of the portfolio, ranked #110.

Prostatis Group first reported a position in ICF in Q2 2025 and has held it in 5 quarters since. 370 funds tracked by Wall St. Rank hold ICF as of Q2 2026.

  • Prostatis Group held 7,795 shares of iShares Select U.S. REIT ETF worth $527K as of Q2 2026.
  • Prostatis Group sold 88 iShares Select U.S. REIT ETF shares in Q2 2026, an estimated $5.91K.
  • iShares Select U.S. REIT ETF made up 0.12% of Prostatis Group's portfolio in Q2 2026, its #110 holding.
  • Prostatis Group first reported a position in iShares Select U.S. REIT ETF in Q2 2025 and has held it in 5 quarters since.
  • 370 funds tracked by Wall St. Rank held iShares Select U.S. REIT ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.